Hitchcock masterpieces like Rear Window and foundational efforts like Peeping Tom are just some of the classic thrillers ...

The Marvel Cinematic Universe isn’t collapsing under its own weight yet, but Kevin Feige is trying to lay down the ...

It’s been about a year since Patrick Gilligan took the helm of Point32Health, the state’s second-largest health insurer and ...

Arrowhead Pharmaceuticals (ARWR) stock hits a 52-week high as analysts cheer a late-stage trial win for the company's ...

Barcelona has signed American goalkeeper Tyler McCamey for its European-champion women's team, the Spanish club said Saturday. The 24-year-old McCamey, a Princeton graduate, played for Dallas Trinity ...

They may not make the music or mastermind the marketing campaigns, but — duh! — the music business wouldn’t and couldn’t ...

For the first time in nearly a decade, the future of “Star Trek” has no clear course as Paramount eyes movies over streaming ...

Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While ...

Republican Vivek Ramaswamy is poised to become Ohio’s first billionaire governor if he prevails in his tight race against ...

Dyne Therapeutics wins FDA Priority Review for DMD drug z-rostudirsen, with key catalysts and pipeline upside. Click for more ...

If approved, encaleret will be the first and only approved therapy specifically indicated for individuals living with ADH1, representing a potential blockbuster opportunity for BridgeBio - Encaleret ...